United States · FDA National Drug Code directory

FASLODEX

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0310-0720_9541dd80-09f9-4d3c-bb2a-fc354e198a2e
Product NDC
0310-0720
Form
INJECTION
Composition / generic term
Fulvestrant
Labeler
AstraZeneca Pharmaceuticals LP
Marketing category
NDA
Marketing start / end (source format)
20101101
Source listing expiry
20271231

Source-listed ingredients

  • FULVESTRANT — 50 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 2 SYRINGE, GLASS in 1 CARTON (0310-0720-10) / 5 mL in 1 SYRINGE, GLASS · 0310-0720-10

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
FASLODEX — United States | Molindra Medicines